Gary Phillips

Gary Phillips

Chairman bei NANOBIOTIX

Vermögen: 48 435 $ am 31.03.2024

58 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Gary M.
Phillips
currently works at OrphoMed, Inc., as President & Chief Executive Officer from 2018, Nanobiotix SA, as Chairman-Supervisory Board from 2021, Aldeyra Therapeutics, Inc., as Independent Director from 2009, Rheon Medical SA, as Director, Helio Vision, Inc., as Director, and Anaveon AG, as Chief Business Officer.
Dr. Phillips also formerly worked at Envisia Therapeutics, Inc., as Executive Chairman, Inotek Pharmaceuticals Corp., as Director, Zyla Life Sciences LLC, as Independent Director from 2019 to 2020, Novartis Pharmaceuticals Corp., as Executive Director-Strategic Planning from 2000 to 2002, Bausch & Lomb, Inc., as President-U.S.
Surgical & Pharmaceuticals from 2002 to 2008, Mallinckrodt Plc, as Chief Strategy Officer & Executive Vice President, Towers Perrin, Inc., as Managing Consultant from 1997 to 1999, Forum Mondial de L'Economie, as Head-Global Health & Healthcare from 2012 to 2013, Mallinckrodt Brand Pharmaceuticals LLC, as Chief Strategy Officer & Executive Vice President from 2013 to 2018, Reckitt Benckiser Pharmaceuticals, Inc., as President from 2011 to 2012, and Towers Watson & Co., as Managing Consultant.
Dr. Phillips received his Masters Business Admin degree in 1991 from The Wharton School of the University of Pennsylvania, doctorate degree in 1992 from Perelman School of Medicine, and undergraduate degree in 1987 from The College of Arts & Sciences.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
07.09.2023 14 812 ( 0,03% ) 48 435 $ 31.03.2024

Aktive Positionen von Gary Phillips

UnternehmenPositionBeginn
ALDEYRA THERAPEUTICS, INC. Director/Board Member 01.05.2009
NANOBIOTIX Chairman 25.05.2021
Director/Board Member -
Chief Executive Officer 23.04.2018
Director/Board Member -
Corporate Officer/Principal -
Alle aktiven Positionen von Gary Phillips

Ehemalige bekannte Positionen von Gary Phillips

UnternehmenPositionEnde
ZYLA LIFE SCIENCES Director/Board Member 20.05.2020
Corporate Officer/Principal 01.03.2018
Corporate Officer/Principal 01.09.2013
░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░ ░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Gary Phillips im Detail an

Ausbildung von Gary Phillips

The Wharton School of the University of Pennsylvania Masters Business Admin
Perelman School of Medicine Doctorate Degree
The College of Arts & Sciences Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Gary Phillips im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

20

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
ALDEYRA THERAPEUTICS, INC.

Health Technology

MALLINCKRODT PLC

Health Technology

NANOBIOTIX

Health Technology

Private Unternehmen14

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Gary Phillips